| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8647573 | Multiple Sclerosis and Related Disorders | 2018 | 8 Pages |
Abstract
This case report illustrates the limits of MS and NMO-Spectrum Disorder classification and challenges the criteria of therapeutic failure within the 6 months after rituximab initiation.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Elisabeth Maillart, Anaïs Lippi, Catherine Lubetzki, Céline Louapre, Caroline Papeix,